[132] Other estimates have shown that MASLD and MASH were found to worsen with cirrhosis in respectively 23% and 1520% of the people over a 1020 year period
Several pharmaceutical manufacturers are working to develop pill-based alternatives to injectable treatments
**Oral semaglutide (most restrictive):** Daily pill, but must be taken on an empty stomach with minimal water and followed by a 30-minute fast
Despite the intake of some calories, the body is tricked into thinking that there is an ongoing fast, which allows for the metabolic changes we seek
Does my health profile qualify me for GLP-1 therapy
Conclusion Results from a large US administrative claims database revealed that, compared with the use of a DPP-4i, OW GLP-1 RA use among people with T2D and established ASCVD is associated with 26% lower ischemic stroke risk and 22% lower MI risk, along with significant reductions in ASCVD-related hospitalizations and outpatient visits